These results are consistent with our previous finding that obesity-mediated Ca2+-PIPs prevent membrane localization of AKT PH domains in vivo15 and suggest that candesartan inhibits the formation of obesity-mediated Ca2+-PIPs, leading to improved insulin signaling. This evidence concerns the gene AKT1 and obesity disorder.